Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $279.44 | 15 | 93.9% |
| Education | $18.09 | 1 | 6.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $144.81 | 8 | $0 (2024) |
| ABBVIE INC. | $39.14 | 2 | $0 (2024) |
| GlaxoSmithKline, LLC. | $29.78 | 2 | $0 (2021) |
| Takeda Pharmaceuticals U.S.A., Inc. | $27.70 | 1 | $0 (2021) |
| SANOFI PASTEUR INC. | $20.78 | 1 | $0 (2024) |
| PFIZER INC. | $19.26 | 1 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $16.06 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $170.65 | 9 | Merck Sharp & Dohme LLC ($91.47) |
| 2023 | $31.67 | 2 | Merck Sharp & Dohme LLC ($31.67) |
| 2021 | $63.33 | 3 | Takeda Pharmaceuticals U.S.A., Inc. ($27.70) |
| 2017 | $31.88 | 2 | Boehringer Ingelheim Pharmaceuticals, Inc. ($16.06) |
All Payment Transactions
16 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), GARDASIL 9, VAXELIS | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: VACCINE | ||||||
| 11/13/2024 | Merck Sharp & Dohme LLC | VAXELIS (Biological) | Education | In-kind items and services | $18.09 | General |
| Category: VACCINE | ||||||
| 10/21/2024 | PFIZER INC. | TRUMENBA (Biological), PREVNAR 20, COMIRNATY | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: VACCINES | ||||||
| 10/09/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), GARDASIL 9, VAXELIS | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: VACCINE | ||||||
| 07/17/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), VAXNEUVANCE, GARDASIL 9 | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: VACCINE | ||||||
| 05/29/2024 | SANOFI PASTEUR INC. | FLUZONE QUADRIVALENT NORTHERN HEMISPHERE (Biological), BEYFORTUS | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: Vaccines | ||||||
| 05/29/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: NEUROSCIENCE | ||||||
| 03/19/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: NEUROSCIENCE | ||||||
| 01/17/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), GARDASIL 9, VAXELIS | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: VACCINE | ||||||
| 11/07/2023 | Merck Sharp & Dohme LLC | ROTATEQ (Biological), GARDASIL 9, VAXELIS | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: VACCINE | ||||||
| 06/21/2023 | Merck Sharp & Dohme LLC | GARDASIL 9 (Biological), VAXNEUVANCE | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: VACCINE | ||||||
| 08/18/2021 | Takeda Pharmaceuticals U.S.A., Inc. | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $27.70 | General |
| Category: NEUROSCIENCE | ||||||
| 08/04/2021 | GlaxoSmithKline, LLC. | BEXSERO (Biological) | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: VACCINES | ||||||
| 07/21/2021 | Merck Sharp & Dohme Corporation | GARDASIL 9 (Biological), ROTATEQ, VAQTA | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: VACCINE | ||||||
| 10/26/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA (Drug) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: RESPIRATORY | ||||||
| 06/29/2017 | GlaxoSmithKline, LLC. | BEXSERO (Biological), MENVEO | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: VACCINES | ||||||
About Dr. Cheryl Clay, M.D
Dr. Cheryl Clay, M.D is a Pediatrics healthcare provider based in Ontario, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/24/2007. The National Provider Identifier (NPI) number assigned to this provider is 1093926693.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Cheryl Clay, M.D has received a total of $297.53 in payments from pharmaceutical and medical device companies, with $170.65 received in 2024. These payments were reported across 16 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($279.44).
Practice Information
- Specialty Pediatrics
- Location Ontario, OH
- Active Since 05/24/2007
- Last Updated 12/28/2020
- Taxonomy Code 208000000X
- Entity Type Individual
- NPI Number 1093926693
Products in Payments
- GARDASIL (Biological) $73.38
- GARDASIL 9 (Biological) $39.39
- BEXSERO (Biological) $29.78
- VYVANSE (Drug) $27.70
- QULIPTA (Drug) $21.18
- FLUZONE QUADRIVALENT NORTHERN HEMISPHERE (Biological) $20.78
- TRUMENBA (Biological) $19.26
- VAXELIS (Biological) $18.09
- UBRELVY (Drug) $17.96
- SPIRIVA (Drug) $16.06
- ROTATEQ (Biological) $13.95
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in Ontario
Dr. Sushil Anand, M.d, M.D
Pediatrics — Payments: $1,296
Kevin Wade, M.d, M.D
Pediatrics — Payments: $862.45
Catareya Liep, Md, MD
Pediatrics — Payments: $606.35
Stephen Ames, M.d, M.D
Pediatrics — Payments: $598.84
Dianne Quintana, M.d, M.D
Pediatrics — Payments: $438.59
Victor Moneme, M.d, M.D
Pediatrics — Payments: $284.30